|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.090 USD | -4.50% |
|
+0.79% | -42.29% |
| 08-05 | Vanda Pharmaceuticals Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Vanda Pharmaceuticals Inc. Reiterates Revenue Guidance for the Full-Year 2026 | CI |
| Market Cap | 306M 265M 247M 227M 429M 29.11B 434M 2.9B 1.14B 14.56B 1.15B 1.12B 48.23B | P/E 2026 * |
-2.24x | P/E 2027 * | -6.61x |
|---|---|---|---|---|---|
| Enterprise Value | 306M 265M 247M 227M 429M 29.11B 434M 2.9B 1.14B 14.56B 1.15B 1.12B 48.23B | EV / Sales 2026 * |
1.17x | EV / Sales 2027 * | 0.86x |
| Free-Float |
90.02% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vanda Pharmaceuticals Inc.
| 1 day | -4.50% | ||
| 1 week | +0.79% | ||
| Current month | -0.20% | ||
| 1 month | -18.04% | ||
| 3 months | -31.12% | ||
| 6 months | -29.60% | ||
| Current year | -42.29% |
| 1 week | 4.95 |  | 5.41 |
| 1 month | 4.94 | | 6.62 |
| Current year | 4.94 | | 9.94 |
| 1 year | 4.14 | | 9.94 |
| 3 years | 3.3 | | 9.94 |
| 5 years | 3.3 | | 21.44 |
| 10 years | 3.3 | | 33.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 2003-04-30 | |
Kevin Moran
DFI | Director of Finance/CFO | 42 | 2020-03-14 |
Scott Howell
HRO | Human Resources Officer | 51 | 2019-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2021-05-31 | |
Richard Dugan
BRD | Director/Board Member | 84 | 2005-11-30 |
Phaedra Chrousos
BRD | Director/Board Member | 46 | 2019-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/23/26 | Sell | Director | 30,000 | 0.0508% | ||
| 2/18/26 | Free | Chief Executive Officer | 525,000 | 0.8884% | ||
| 2/18/26 | Free | Chief Financial Officer | 125,000 | 0.2115% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.50% | +0.79% | +20.90% | -13.14% | 306M | |
| +4.35% | +16.60% | +58.11% | +95.21% | 64.9B | |
| +2.32% | +2.57% | +31.45% | +73.22% | 54.05B | |
| +0.91% | -0.83% | -17.01% | -13.43% | 23.16B | |
| +0.27% | -3.98% | -11.28% | +350.30% | 21.46B | |
| +1.87% | +9.47% | +30.87% | -5.63% | 21.25B | |
| +0.73% | +3.31% | +38.34% | -25.03% | 17.94B | |
| +9.88% | +23.61% | +222.87% | +385.49% | 17.03B | |
| +3.29% | +5.61% | +21.01% | +636.23% | 14.99B | |
| +1.25% | +2.48% | +51.36% | +179.72% | 14.25B | |
| Average | +2.03% | +4.61% | +44.66% | +166.29% | 24.93B | |
| Weighted average by Cap. | +2.89% | +5.90% | +44.22% | +142.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 259M 224M 209M 192M 363M 24.62B 367M 2.46B 964M 12.32B 972M 951M 40.8B | 356M 309M 288M 265M 500M 33.9B 505M 3.38B 1.33B 16.96B 1.34B 1.31B 56.17B |
| Net income | -184M -160M -149M -137M -258M -17.51B -261M -1.75B -686M -8.76B -692M -677M -29.02B | -62.73M -54.33M -50.65M -46.58M -87.94M -5.96B -88.92M -595M -234M -2.98B -236M -230M -9.88B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | US$5.090 | -4.50% | 1,601,206 |
| 26-08-04 | US$5.330 | +1.91% | 727,495 |
| 26-08-03 | US$5.230 | +2.55% | 719,844 |
| 26-07-31 | US$5.100 | -1.54% | 540,608 |
| 26-07-30 | US$5.180 | +2.57% | 990,083 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VNDA Stock
Select your edition
All financial news and data tailored to specific country editions
